Maraviroc modelling strategy use of early phase 1 data to support a semi-mechanistic population pharmacokinetic model.PDFVIP

  • 15
  • 0
  • 约29.47万字
  • 约 15页
  • 2016-02-08 发布于天津
  • 举报

Maraviroc modelling strategy use of early phase 1 data to support a semi-mechanistic population pharmacokinetic model.PDF

Maraviroc modelling strategy use of early phase 1 data to support a semi-mechanistic population pharmacokinetic model.PDF

British Journal of Clinical DOI:10.1111/j.1365-2125.2009.03455.x Pharmacology Correspondence Maraviroc modelling Barry Weatherley PhD, Pharmacometrics, Pfizer Global Research and Development,

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档